Analyst Update: Potash Corp, Conatus Pharma, Horizon Pharma

Analysts adjusted their ratings on Potash Corp./Saskatchewan (USA) (POT), Conatus Pharmaceuticals Inc (CNAT), and Horizon Pharma PLC (HZNP)

Sep 22, 2015 at 12:59 PM
facebook X logo linkedin



Analysts chimed in on fertilizer producer Potash Corp./Saskatchewan (USA) (NYSE:POT), as well as biotechnology concerns Conatus Pharmaceuticals Inc (NASDAQ:CNAT) and Horizon Pharma PLC (NASDAQ:HZNP).  Here's a quick roundup of today's brokerage notes on POT, CNAT, and HZNP.

  • CNAT is 9.2% higher at $4.74, bucking the broad-market trend, after H.C. Wainwright started the stock with a "buy" rating and a $15 price target -- more than three times the stock's current price. The brokerage firm attributed the upbeat opinion to the prospects for emricasan, CNAT's liver drug. On Aug. 26, shares of Conatus Pharmaceuticals Inc hit a record low of $3.44, but have bounced back, adding roughly 21% in September alone. What's more, today's rally has the stock trading above its 80-day moving average for the first time since June. 
  • Finally, HZNP is headed in the opposite direction of its sector mate CNAT, dropping 12.5% to $25.38. Horizon Pharma PLC dropped after Brean cut the equity to "hold" from "buy," citing "unsettling" developments -- including the belief that a Depomed (NASDAQ:DEPO) deal won't happen. Despite today's drop, HZNP has almost doubled in 2015, but is in danger of breaching its 200-day moving average for the first time this year. Should the stock continue to fall, there could be some pressure from downgrades, as all seven of the brokerages rating HZNP feel it worthy of a "buy" or better.
For other stocks in analysts' crosshairs, read Analyst Upgrades: Halozyme Therapeutics, Inc., Nike Inc, and EMC Corporation and Analyst Downgrades: Red Hat Inc, Caterpillar Inc., and Mosaic Co
 

Unlock Weekend Profits with Chris Prybal's Favorite Strategy Up +487.5% in 2024

With the markets going left, right, and sideways, you need to have a plan now more than ever. 

Expert Trader Chris Prybal is no stranger to volatility, and has mastered finding big stock rallies while other traders aren't looking over the weekend. Rallies that produced gains like +207% on RTX calls, +236% on MARA calls, and +238% on NET calls.

A few simple moves on Sunday at 7pm could be the “Secret Sauce” your portfolio needs to not just stay afloat, but make unprecedented gains in this turbulent market.


Don’t sit on the sidelines, beat the market with Chris Prybal's strategy. Join him now!

 

 
 
 


 
 

Rainmaker Ads CGI